fda drug shortage list semaglutide status january 2025 Federal judge upholds FDA's removal of Ozempic, Wegovy from GLP-1 No Longer on FDA's – Drug compounders sue over weight

Oral semaglutide still carries the gastric emptying interaction risk, though some research suggests the effect may be less pronounced than initially feared

The freeze-dried format helps maintain research material integrity during storage and transport in qualified laboratory settings

Yes, most Aetna plans that cover Wegovy require prior authorization

Microdose semaglutide uses a lower-dose strategy intended to be gentler, slower, and potentially easier to tolerate

Semaglutide for Metabolic Dysfunction-Associated Steatohepatitis [PMID: 40466070] Laboratory literature summary: Semaglutide for Metabolic Dysfunction-Associated Steatohepatitis